Abon Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABON PHARMS LLC, and what generic and branded alternatives to ABON PHARMS LLC drugs are available?
ABON PHARMS LLC has four approved drugs.
Summary for Abon Pharms Llc
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Abon Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abon Pharms Llc | CLOFARABINE | clofarabine | SOLUTION;INTRAVENOUS | 204029-001 | May 9, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abon Pharms Llc | SUCRALFATE | sucralfate | SUSPENSION;ORAL | 216726-001 | Mar 21, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abon Pharms Llc | GABAPENTIN | gabapentin | TABLET;ORAL | 203643-001 | Sep 9, 2024 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abon Pharms Llc | ATOVAQUONE | atovaquone | SUSPENSION;ORAL | 214272-001 | Oct 25, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
